You have free access to this content

Clinical Cardiology

Cover image for Clinical Cardiology

Supplement: Advances in ACE Inhibitor Therapy: A Symposium

June 1990

Volume 13, Issue S7

Pages fmi–fmi, VII-4–VII-52

  1. Masthead

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      Masthead (page fmi)

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131401

  2. Introductions

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      Introduction (pages VII-4–VII-5)

      William Frishman

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131402

  3. Preclinical Datas

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      Quinapril: Overview of preclinical data (pages VII-6–VII-12)

      Harvey R. Kaplan, D. G. Taylor and S. C. Olson

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131403

  4. Clinical Developments

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      Overview of the clinical development of quinapril (pages VII-13–VII-18)

      Graham J. Frank

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131404

  5. Treatment of Mild to Moderate Hypertensions

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
  6. Treatment of Moderate to Severe Hypertensions

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
  7. Heart Failure Treatments

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      ACE inhibitors in the treatment of heart failure (pages VII-32–VII-38)

      Robert DiBianco

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131407

  8. Safety Profiles

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      The safety profile of quinapril: Is there a difference among ACE inhibitors? (pages VII-39–VII-42)

      David Canter, G. J. Frank, L. E. Knapp and R. W. McLain

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131408

  9. Risk Factors and Atherogenesis

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
  10. Treatment of Arrhythmias

    1. Top of page
    2. Masthead
    3. Introductions
    4. Preclinical Datas
    5. Clinical Developments
    6. Treatment of Mild to Moderate Hypertensions
    7. Treatment of Moderate to Severe Hypertensions
    8. Heart Failure Treatments
    9. Safety Profiles
    10. Risk Factors and Atherogenesis
    11. Treatment of Arrhythmias
    1. You have free access to this content
      The role of ACE inhibitors in the treatment of arrhythmias (pages VII-49–VII-52)

      William J. McKenna and G. A. Haywood

      Article first published online: 30 SEP 2009 | DOI: 10.1002/clc.4960131410

SEARCH

SEARCH BY CITATION